<SEC-DOCUMENT>0001193125-19-040377-index.html : 20190214
<SEC-HEADER>0001193125-19-040377.hdr.sgml : 20190214
<ACCEPTANCE-DATETIME>20190214145132
ACCESSION NUMBER:		0001193125-19-040377
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20190214
DATE AS OF CHANGE:		20190214
GROUP MEMBERS:		MACQUARIE BANK LTD
GROUP MEMBERS:		MACQUARIE FUNDS MANAGEMENT HONG KONG LTD
GROUP MEMBERS:		MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST
GROUP MEMBERS:		MACQUARIE INVESTMENT MANAGEMENT HOLDINGS INC

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vanda Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001347178
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				030491827
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-82196
		FILM NUMBER:		19604922

	BUSINESS ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037
		BUSINESS PHONE:		202-734-3400

	MAIL ADDRESS:	
		STREET 1:		2200 PENNSYLVANIA AVE NW
		STREET 2:		SUITE 300E
		CITY:			WASHINGTON
		STATE:			DC
		ZIP:			20037

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACQUARIE GROUP LTD
		CENTRAL INDEX KEY:			0001418333
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		50 MARTIN PLACE
		CITY:			SYDNEY, NSW 2000
		STATE:			C3
		ZIP:			2000
		BUSINESS PHONE:		212.231.1000

	MAIL ADDRESS:	
		STREET 1:		50 MARTIN PLACE
		CITY:			SYDNEY, NSW 2000
		STATE:			C3
		ZIP:			2000
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>d686004dsc13ga.htm
<DESCRIPTION>AMENDMENT NO. 1 TO SCHEDULE 13G
<TEXT>
Document 1 - file: d686004dsc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>